id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0081-0003,FDA,FDA-1999-D-0081,Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors,Supporting & Related Material,Guidance,2006-11-27T05:00:00Z,2006,11,,,2025-07-01T21:52:54Z,,0,0,09000064804a6962